HUMANIZED ANTIBODIES SPECIFIC FOR MYELOMA AND OVARIAN CANCER CELLS
The disclosure provides for humanized antibodies, and fragments thereof, that are capable of binding to and killing human myeloma and ovarian cancer cells. The antibodies and their fragments are useful for therapeutic, diagnostic, and research purposes.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
04.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The disclosure provides for humanized antibodies, and fragments thereof, that are capable of binding to and killing human myeloma and ovarian cancer cells. The antibodies and their fragments are useful for therapeutic, diagnostic, and research purposes. |
---|---|
AbstractList | The disclosure provides for humanized antibodies, and fragments thereof, that are capable of binding to and killing human myeloma and ovarian cancer cells. The antibodies and their fragments are useful for therapeutic, diagnostic, and research purposes. |
Author | GELBER, Cohava |
Author_xml | – fullname: GELBER, Cohava |
BookMark | eNrjYmDJy89L5WRw8gj1dfTzjHJ1UXD0C_F08nfxdA1WCA5wdfZ083RWcPMPUvCNdPXx93UEyrso-Ic5Bnk6-ik4O_o5uwYpOLv6-ATzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjAyNjQ2MLUyMDR0Nj4lQBALNJLZk |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
ExternalDocumentID | US2023138520A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2023138520A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:06:58 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2023138520A13 |
Notes | Application Number: US202117793603 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230504&DB=EPODOC&CC=US&NR=2023138520A1 |
ParticipantIDs | epo_espacenet_US2023138520A1 |
PublicationCentury | 2000 |
PublicationDate | 20230504 |
PublicationDateYYYYMMDD | 2023-05-04 |
PublicationDate_xml | – month: 05 year: 2023 text: 20230504 day: 04 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | CAERUS THERAPEUTICS, INC |
RelatedCompanies_xml | – name: CAERUS THERAPEUTICS, INC |
Score | 3.4640532 |
Snippet | The disclosure provides for humanized antibodies, and fragments thereof, that are capable of binding to and killing human myeloma and ovarian cancer cells. The... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE |
Title | HUMANIZED ANTIBODIES SPECIFIC FOR MYELOMA AND OVARIAN CANCER CELLS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230504&DB=EPODOC&locale=&CC=US&NR=2023138520A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5Kfd60KlWrLCi5BZtmY3sJkmw2NNI8aJpSvZQ03YAgaTER_76TpdWeetwZWPY1O9_szgPgES_DPk1pqlKhGSrVc6oO6rPc7-aIDjTRy2VtQD94Hib0dWbMGvC5jYWReUJ_ZHJElKgM5b2S9_X6_xHLkb6V5dPiA0mrF3diOsrGOkY8beCmO7bJo9AJmcKYmcRKMJY8TR8Yva6FttIBAul-LQ98atdxKetdpeKewWGE_RXVOTRE0YITtq291oJjf_Pl3YIj6aOZlUjcyGF5AfYw8a3Ae-cOsYKJZ4c1qiNxxJnneoygZUf8Nz4KfQv5Dgmn1tizAsLqSjRjwvhoFF_Cg8snbKjisOZ_qzBP4t056FfQLFaFaAOhaJQYqdARmmVURrbqvUxbZt2loCmij2vo7OvpZj_7Fk7rpvTxox1oVl_f4g71cLW4l8v3C85Igv0 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_MA3RY0fqE00vC0y1gkvxGxdl033QdhG0JdljJKYmEFkxn_fWwPKE693yaW99nq_a-96AA94GPZoRjOFClVXqDanSr_ay73OHNGBKrpz2RvQD56chL5M9EkNPje1MPKf0B_5OSJaVI72Xsrzevl_iWXJ3MrV4_QDSYtnOx5Y7XV0jHhax0W3zAEfhlbI2owNkqgdjCRP1fp6t2NgrLSHILtX2QMfm1VdynLbqdjHsD9EeUV5AjVRNKHBNr3XmnDor5-8m3AgczTzFRLXdrg6BdNJfCNw37lFjCB2zbBCdSQacubaLiMY2RH_jXuhbyDfIuHYGLlGQFjViWZEGPe86AzubR4zR8FhpX9aSJNoew7aOdSLRSEugFAMSvRMaAjNciorW7Vurs7yzkzQDNHHJbR2Sbrazb6DhhP7Xuq5wes1HFUsme9HW1Avv77FDfrkcnorVfkLH1KF8A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HUMANIZED+ANTIBODIES+SPECIFIC+FOR+MYELOMA+AND+OVARIAN+CANCER+CELLS&rft.inventor=GELBER%2C+Cohava&rft.date=2023-05-04&rft.externalDBID=A1&rft.externalDocID=US2023138520A1 |